12/17
06:42 am
neo
3 Stocks Under $50 We Steer Clear Of [Yahoo! Finance]
Low
Report
3 Stocks Under $50 We Steer Clear Of [Yahoo! Finance]
12/15
07:50 am
neo
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation [Yahoo! Finance]
Low
Report
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation [Yahoo! Finance]
12/15
07:05 am
neo
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
Low
Report
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
12/10
07:42 am
neo
NeoGenomics to Present New ctDNA Research at SABCS 2025 [Yahoo! Finance]
Low
Report
NeoGenomics to Present New ctDNA Research at SABCS 2025 [Yahoo! Finance]
12/10
07:05 am
neo
NeoGenomics to Present New ctDNA Research at SABCS 2025
Low
Report
NeoGenomics to Present New ctDNA Research at SABCS 2025
12/8
08:05 am
neo
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
Low
Report
NeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
12/5
03:05 pm
neo
Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO) [Yahoo! Finance]
Low
Report
Testing & Diagnostics Services Stocks Q3 Recap: Benchmarking NeoGenomics (NASDAQ:NEO) [Yahoo! Finance]
11/25
01:54 pm
neo
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/18
01:18 pm
neo
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/12
01:27 pm
neo
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/10
06:58 am
neo
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off [Yahoo! Finance]
Medium
Report
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off [Yahoo! Finance]
11/7
01:14 am
neo
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/6
07:05 am
neo
NeoGenomics to Participate in Upcoming Investor Conferences
Low
Report
NeoGenomics to Participate in Upcoming Investor Conferences
10/30
12:51 pm
neo
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
Medium
Report
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
10/30
09:32 am
neo
NeoGenomics (NEO): Losses Widen, Profitability Still Elusive as Revenue Trails Market Growth [Yahoo! Finance]
Medium
Report
NeoGenomics (NEO): Losses Widen, Profitability Still Elusive as Revenue Trails Market Growth [Yahoo! Finance]
10/28
06:02 pm
neo
NeoGenomics (NASDAQ:NEO) was given a new $14.00 price target on by analysts at Leerink Partners.
Medium
Report
NeoGenomics (NASDAQ:NEO) was given a new $14.00 price target on by analysts at Leerink Partners.
10/28
07:05 am
neo
NeoGenomics Reports Third Quarter 2025 Results
Medium
Report
NeoGenomics Reports Third Quarter 2025 Results
10/14
07:21 am
neo
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 [Yahoo! Finance]
Low
Report
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025 [Yahoo! Finance]
10/14
07:05 am
neo
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
Low
Report
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
10/8
12:30 pm
neo
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
10/7
07:05 am
neo
NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025
Low
Report
NeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025
10/2
04:00 pm
neo
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know [Yahoo! Finance]
Low
Report
agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know [Yahoo! Finance]
9/28
07:41 am
neo
NeoGenomics (NEO): Exploring Current Valuation After Recent Share Price Volatility [Yahoo! Finance]
Medium
Report
NeoGenomics (NEO): Exploring Current Valuation After Recent Share Price Volatility [Yahoo! Finance]